Stimuli-Responsive Graphene Nanohybrids for Biomedical Applications

<div>(a) Demonstrated antibacterial properties of the membranes based on the plate counting method: (A<span class="nowrap"><svg height="11.4859pt" id="M15" style="vertical-align:-0.04979992pt" version="1.1" viewbox="-0.0498162 -11.4361 3.89517 11.4859" width="3.89517pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.0091,0,0,-0.0091,0,-5.741)"><path d="M310 541L304 571C290 586 211 619 185 610L80 76L131 52L310 541Z"></path></g></svg>)</span> control without membrane, (B<span class="nowrap"><svg height="11.4859pt" id="M16" style="vertical-align:-0.04979992pt" version="1.1" viewbox="-0.0498162 -11.4361 3.89517 11.4859" width="3.89517pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.0091,0,0,-0.0091,0,-5.741)"><path d="M310 541L304 571C290 586 211 619 185 610L80 76L131 52L310 541Z"></path></g></svg>)</span> HPAN membrane, (C) PDA membrane, (D) PDA-GO2 membrane, (E) PDA-rGOC2 membrane, and (F) PDA-rGOC3 membrane. (b) Quantified antimicrobial ability of the HPAN, PDA-modified, and codeposition-modified membranes [<a href="/journals/sci/2019/9831853/#B122">122</a>].</div>

Stem Cells International

Stimuli-Responsive Graphene Nanohybrids for Biomedical Applications

Figure 11